MRI Interventions (MRIC) stock price, revenue, and financials

MRI Interventions market cap is $80.5 m, and annual revenue was $11.22 m in FY 2019

$80.5 M

MRIC Mkt cap, 25-Mar-2020

$11.2 M

MRI Interventions Revenue FY, 2019
MRI Interventions Gross profit (FY, 2019)7.4 M
MRI Interventions Gross profit margin (FY, 2019), %65.8%
MRI Interventions Net income (FY, 2019)-5.5 M
MRI Interventions EBIT (FY, 2019)-4.6 M
MRI Interventions Cash, 31-Dec-20195.7 M
MRI Interventions EV77.2 M

MRI Interventions Revenue

MRI Interventions revenue was $11.22 m in FY, 2019

Embed Graph

MRI Interventions Revenue Breakdown

Embed Graph

MRI Interventions revenue breakdown by business segment: 9.1% from Service and Other and 90.9% from Product

MRI Interventions Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.7m7.4m7.4m11.2m

Revenue growth, %

25%28%0%

Cost of goods sold

2.6m2.9m2.4m3.8m

Gross profit

3.1m4.5m4.9m7.4m

Gross profit Margin, %

54%61%67%66%

Sales and marketing expense

4.0m3.5m4.8m

R&D expense

2.6m2.8m2.3m2.9m

General and administrative expense

8.0m4.0m4.3m4.3m

Operating expense total

10.6m10.8m10.2m12.0m

EBIT

(7.5m)(6.3m)(5.2m)(4.6m)

EBIT margin, %

(130%)(86%)(71%)(41%)

Interest expense

1.1m872.9k980.4k

Interest income

8.8k

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

MRI Interventions Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.3m9.3m3.1m5.7m

Accounts Receivable

865.9k949.4k1.2m1.1m

Prepaid Expenses

135.0k192.7k213.7k357.2k

Inventories

1.8m2.3m2.1m3.2m

Current Assets

6.1m12.7m6.7m10.4m

PP&E

328.2k267.7k377.7k447.2k

Total Assets

7.4m13.9m7.9m11.9m

Accounts Payable

1.5m759.4k500.9k965.8k

Short-term debt

2.0m113.5k

Current Liabilities

3.0m4.4m2.0m3.8m

Long-term debt

2.0m2.3m

Total Debt

2.0m2.0m2.5m

Total Liabilities

8.2m8.1m6.3m7.3m

Common Stock

36.2k106.9k110.2k152.4k

Additional Paid-in Capital

93.1m106.8m108.6m117.2m

Retained Earnings

(93.9m)(101.0m)(107.2m)(112.7m)

Total Equity

(756.1k)5.8m1.5m4.6m

Debt to Equity Ratio

-2.6 x0.3 x

Debt to Assets Ratio

0.3 x0.1 x

Financial Leverage

-9.8 x2.4 x5.2 x2.6 x

MRI Interventions Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

Depreciation and Amortization

155.7k116.5k109.4k250.6k

Accounts Receivable

352.1k(83.5k)(284.5k)144.0k

Inventories

72.3k(469.9k)122.2k(1.0m)

Accounts Payable

178.4k(512.4k)(284.3k)1.2m

Cash From Operating Activities

(5.8m)(6.0m)(4.6m)(2.8m)

Purchases of PP&E

(101.0k)(26.8k)(63.5k)(10.2k)

Cash From Investing Activities

(101.0k)(26.8k)(63.5k)(160.2k)

Long-term Borrowings

(2.0m)(2.1m)

Cash From Financing Activities

3.8m12.0m(1.5m)5.6m

Net Change in Cash

(2.1m)6.0m(6.2m)2.6m

Interest Paid

976.3k348.5k210.7k316.6k

MRI Interventions Ratios

USDY, 2019

EV/EBIT

-16.8 x

EV/CFO

-27.1 x

Revenue/Employee

295.2k

Financial Leverage

2.6 x

MRI Interventions Operating Metrics

Nov, 2019

Industry Partners

3

Patent Applications

95

Patents Issued

95